FDA Inspection 1163006 — Celex Laboratories Inc.
The FDA completed an inspection of Celex Laboratories Inc. on February 25, 2022 in Richmond. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 6 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Richmond (Canada)
Citations
| ID | CFR | Description |
|---|---|---|
| 15673 | 21 CFR 111.315(a) | Criteria for establishing specifications |
| 15825 | 21 CFR 111.65 | Quality control - quality, dietary supplement |
| 15829 | 21 CFR 111.70(b)(1) | Specifications - component identity |
| 15839 | 21 CFR 111.70(e) | Specifications - identity, purity, strength, composition |
| 15882 | 21 CFR 111.75(h) | Tests, examinations - scientifically valid |
| 15931 | 21 CFR 111.105 | Quality control - packaged, labeled |